Molecular Respiratory Panels Market : Global Industry Analysis and Opportunity Assessment, 2035

Molecular Respiratory Panels Market Size and Share Forecast Outlook 2025 to 2035

The Molecular Respiratory Panels Market is estimated to be valued at USD 1.2 billion in 2025 and is projected to reach USD 2.2 billion by 2035, registering a compound annual growth rate (CAGR) of 6.0% over the forecast period.

Quick Stats for Molecular Respiratory Panels Market

• Molecular Respiratory Panels Market Industry Value (2025): USD 1.2 billion
• Molecular Respiratory Panels Market Forecast Value (2035): USD 2.2 billion
• Molecular Respiratory Panels Market Forecast CAGR: 6.0%
• Leading Segment in Molecular Respiratory Panels Market in 2025: Multiplex Panels (48.7%)
• Key Growth Region in Molecular Respiratory Panels Market: North America, Asia-Pacific, Europe
• Top Key Players in Molecular Respiratory Panels Market: Roche Diagnostics, Siemens Healthineers, Advanced Molecular Diagnostics (AMD), Illumina Inc., Helvetica Healthcare, Qiagen, Jant Pharmacal Corporation, Trivitron Healthcare, Thermo Fisher Scientific, Cepheid, Bioneer Corporation, BioFire Diagnostics (Biomerieux), Antylia Scientific Company, Quidel Corporation, DTPM, Luminex Corporation (DiaSorin), Bio-Rad Laboratories

Metric	Value
Molecular Respiratory Panels Market Estimated Value in (2025 E)	USD 1.2 billion
Molecular Respiratory Panels Market Forecast Value in (2035 F)	USD 2.2 billion
Forecast CAGR (2025 to 2035)	6.0%

Rationale for Segmental Growth in the Molecular Respiratory Panels Market

The molecular respiratory panels market is experiencing robust growth as healthcare systems prioritize early detection and comprehensive diagnosis of respiratory infections. Rising incidences of viral and bacterial respiratory illnesses, combined with seasonal flu outbreaks and the lingering impact of COVID 19, are creating strong demand for rapid and accurate testing solutions.

Multiplexing capabilities, which allow simultaneous detection of multiple pathogens, are being increasingly adopted to improve diagnostic efficiency and reduce turnaround times. Advances in molecular techniques such as polymerase chain reaction are further strengthening clinical accuracy and reliability.

Growing awareness of antimicrobial stewardship and the need to reduce inappropriate antibiotic use are also enhancing adoption of molecular respiratory panels. With healthcare infrastructures investing in point of care testing and integrated laboratory workflows, the market outlook remains highly favorable for innovation and sustained adoption.

Segmental Analysis

Insights into the Multiplex Panels Type Segment

The multiplex panels segment is projected to hold 48.70% of total revenue by 2025, making it the leading panel type. This dominance is supported by the ability to simultaneously detect a wide range of pathogens in a single test, reducing the need for multiple assays and saving valuable diagnostic time.

Multiplex formats enable clinicians to identify co infections more effectively, improving treatment accuracy and patient outcomes. Their efficiency in high volume testing and ability to streamline laboratory processes have contributed to their strong adoption.

As healthcare providers continue to emphasize rapid and comprehensive diagnostics, multiplex panels have secured their position as the most influential segment in the molecular respiratory panels market.

Insights into the Diagnostic Use Usage Segment

The diagnostic use segment is anticipated to account for 62.50% of the market share by 2025, positioning it as the most significant usage type. This growth is attributed to the rising demand for accurate patient diagnosis in both hospital and outpatient settings.

Diagnostic use has been prioritized due to the pressing need for timely clinical decisions that guide effective treatment strategies. Additionally, increased investments in healthcare infrastructure and laboratory automation have amplified reliance on diagnostic molecular panels.

Their proven role in reducing misdiagnosis, improving patient outcomes, and supporting evidence based clinical practices has reinforced their prominence within the usage category.

Insights into the Polymerase Chain Reaction Technique Segment

The polymerase chain reaction technique is expected to represent 44.60% of total market revenue by 2025 within the technique category, making it the leading method. PCR has gained this position due to its high sensitivity, specificity, and rapid turnaround time in identifying respiratory pathogens.

Continuous advancements in real time PCR technologies and automated systems have enabled more accurate and efficient testing across both centralized laboratories and point of care environments. The scalability and robustness of PCR platforms have ensured their integration into routine clinical workflows.

As healthcare systems demand reliable and standardized molecular diagnostics, PCR remains the technique of choice, maintaining its leadership in the molecular respiratory panels market.

2020 to 2024 Molecular Respiratory Panels Market Demand Outlook Compared to 2025 to 2035 Forecast

From 2.2020 to 2.202.22.2, the global molecular respiratory panels’ market experienced a CAGR of 9.2.2%, reaching a market size of USD 1.2 million in 2.202.23.

From 2.2020 to 2.202.22.2, the global molecular respiratory panels’’ market industry witnessed steady growth due to the increased prevalence of respiratory illnesses and technological advancements. Significant advances in molecular diagnostic technology have occurred throughout the years, including the creation of polymerase chain reaction (PCR) and other nucleic acid amplification techniques. These technological improvements have enhanced the sensitivity, specificity, and multiplexing capabilities of molecular respiratory panels’, which has contributed to the growth of the market.

Respiratory diseases, such as influenza, respiratory syncytial virus (RSV), and other respiratory pathogens, have long been a source of worry across the world. The growing prevalence of these illnesses has increased need for reliable and speedy diagnostic tests, propelling the molecular respiratory panels’ market forward.

Future Forecast for Molecular Respiratory Panels Market Industry:

Looking ahead, the global molecular respiratory panels’’ market industry is expected to rise at a CAGR of 6.3% from 2.202.23 to 2.2035. During the forecast period, the market size is expected to reach USD 2.2.0 billion by 2.2035.

The molecular respiratory panels’’ market industry is expected to continue its growth trajectory from 2.202.23 to 2.2035. As the benefits and capabilities of molecular respiratory panels’ become more generally recognized, healthcare practitioners are likely to become more aware and employ them. The requirement for accurate and quick diagnosis, as well as infection management and monitoring, will drive the expansion of the molecular respiratory panel market.

The requirement for quick results and decentralized testing will push the need for point-of-care testing to expand further. Molecular respiratory panels’ that may be conducted at the point of treatment, such as in clinics or emergency rooms, are expected to acquire market traction.

Analysis of Key Countries in the Molecular Respiratory Panels Market

Molecular Respiratory Panels Market to Surge in the United States Due to Rising Prevalence of Respiratory Disorders.

Country	The United States
Market Size (USD Million) by End of Forecast Period (2035)	USD 2.2 million
CAGR % 2025 to End of Forecast (2035)	7.0%

The molecular respiratory panels’’ market industry in the United States is expected to reach a market size of USD 2.2 million by 2035, expanding at a CAGR of 7.0%. The incidence of chronic respiratory disorders in the nation is increasing, which is driving up demand for the industry. For instance, the USA Centers for Disease Control and Prevention (CDC) 2025 report showed that in 8 out of 10 public health districts in the USA, the prevalence of respiratory syncytial virus (RSV) is rising.

Rising Demand for Molecular Respiratory Panels Market is Due to the Growing Increasing Awareness and Screening Programs.

Country	The United Kingdom
Market Size (USD Million) by End of Forecast Period (2035)	USD 73.6 million
CAGR % 2025 to End of Forecast (2035)	5.3%

The molecular respiratory panels’’ market industry in the United Kingdom is expected to reach a market share of USD 73.6 million, expanding at a CAGR of 5.3% during the forecast period. Strict laws for the mining sector increase the usage of the molecular respiratory panels’. In the EU there are around 53,000 people employed by coal power stations. The EU’s regulatory body also conducts routine checkups of these workers, which boosts demand for molecular respiratory panels’.

Notable Growth Expected in China's Molecular Respiratory Panels Market as Increasing Prevalence of Respiratory Illnesses.

Country	China
Market Size (USD Million) by End of Forecast Period (2035)	USD 180.6 million
CAGR % 2025 to End of Forecast (2035)	7.7%

The molecular respiratory panels’’ market industry in China is anticipated to reach a market size of USD 180.6 million, moving at a CAGR of 7.7% during the forecast period. The molecular respiratory panel’s market industry in China is expected to grow prominently due to the increasing population with respiratory illness. China has a big population, and respiratory illnesses such as influenza, Respiratory syncytial (RSV), and other respiratory pathogens are common. The rising prevalence of these illnesses is raising the requirement for precise and effective diagnostic techniques such as molecular respiratory panels’.

High Geriatric Population to Drive Market Growth in Japan

Country	Japan
Market Size (USD Million) by End of Forecast Period (2035)	USD 126.0 million
CAGR % 2025 to End of Forecast (2035)	7.4%

The molecular respiratory panels’ market industry in Japan is estimated to reach a market size of USD 126.0 million by 2035, thriving at a CAGR of 7.4%. The market in Japan is predicted to grow because of high geriatric population. Japan has one of the world's oldest populations, and respiratory illnesses such as pneumonia and influenza are widespread among the elderly. The growing older population in Japan, as well as the requirement for precise respiratory illness detection, are projected to boost demand for molecular respiratory panels.

Demand for Molecular Respiratory Panels Market is Rising Due to High Awareness of Respiratory Infections.

Country	South Korea
Market Size (USD Million) by End of Forecast Period (2035)	USD 49.3 million
CAGR % 2025 to End of Forecast (2035)	6.8%

The molecular respiratory panels’ market industry in South Korea is expected to reach a market size of USD 49.3 million, expanding at a CAGR of 6.8% during the forecast period. In the past, South Korea has had outbreaks of respiratory illnesses such as MERS (Middle East Respiratory Syndrome) and COVID-19. These incidents have raised public awareness of respiratory illnesses, resulting in a greater demand for reliable market data.

Molecular Respiratory Panels Market Segmentation by Key Investment Segments

Multiplex Panels to Dominate Molecular Respiratory Panels Market Industry with 55.0% Market Share in 2025

The multiplex panels is to dominate the molecular respiratory panels’ market industry with a market share of 50.4% in 2025. A multiplex molecular diagnostic platform would be a crucial component of a successful respiratory diagnostics method. For the identification of respiratory infections, NADT methods such as loop-mediated isothermal amplification and nucleic acid sequence-based amplification have been utilized.

Multiplexing, in which numerous targets are evaluated at the same time, is often used in PCR-based assays and offers substantial advantages in terms of efficiency and pathogen coverage over single-pathogen tests.

Diagnostic Use to Dominate Molecular Respiratory Panels Market With 65.8% Market Share in 2025.

Diagnostic use is dominating the molecular respiratory panels’ market industry with market share of 65.8% in 2025. Molecular respiratory panels are generally used for diagnostic reasons since they are designed to detect and identify respiratory pathogens at the molecular level, delivering accurate and speedy findings for respiratory infection diagnosis.

Which Technique Is Widely Adopted In the Market?

Reverse transcription polymerase chain reaction (RT-PCR) is dominating the molecular respiratory panels’ market with the market share of 47.8% in 2025. RT-PCR may identify very low quantities of viral genetic material in patient samples. This great sensitivity enables for the early diagnosis of viral infections, even when the viral load is low in the early stages of the disease. It facilitates accurate diagnosis and patient management. This technique's great sensitivity is particularly appealing to healthcare professionals and individuals seeking to diagnose.

Which End User Is Widely Adopted In the Market?

The diagnostic centers dominating the molecular respiratory panels’ market with the market share of 38.1% in 2025. Diagnostic centers often utilize molecular respiratory panels as part of their comprehensive testing services for respiratory infections. These panels offer several advantages, such as the ability to simultaneously test for multiple respiratory pathogens in a single assay, high sensitivity and specificity, and rapid turnaround times.

Competitive Landscape of the Molecular Respiratory Panels Industry

The molecular respiratory panel sector is aggressively competitive, with many companies fighting for market dominance. Key players in the molecular respiratory panels market employ various strategies to stay competitive and maintain their market position.

Key Strategies Used by the Participants

• Product Innovation

Key players invest in research and development activities to continuously improve their molecular respiratory panel products. By offering innovative and advanced products, companies can attract customers and differentiate themselves from competitors.

• Strategic Partnerships and Collaborations

Key players form strategic partnerships and collaborations with other companies, academic institutions, and research organizations. These partnerships facilitate the exchange of knowledge, resources, and technologies, leading to the development of new products and solutions.

• Expansion into Emerging Markets

Companies focus on expanding their presence in different geographic regions. This involves establishing distribution channels, partnerships with local distributors, and obtaining necessary regulatory approvals in target markets.

• Mergers and Acquisitions

Companies in the market may engage in mergers or acquisitions to consolidate their product portfolio, acquire new technologies, these strategic moves allow companies to enter new market segments, gain access to novel products or intellectual property, and achieve synergies in terms of research, manufacturing, or distributions.

Leading Players in the Molecular Respiratory Panels Industry

• Roche Diagnostics
• Siemens Healthineers
• Advanced Molecular Diagnostics (AMD)
• Illumina Inc.
• Helvetica Healthcare
• Qiagen
• Jant Pharmacal Corporation
• Trivitron Healthcare
• Thermo Fisher Scientific
• Cepheid
• Bioneer Corporation
• BioFire Diagnostics (Biomerieux)
• Antylia Scientific Company
• Quidel Corporation
• DTPM
• Luminex Corporation (DiaSorin)
• Bio-Rad Laboratories

Key Developments in the Molecular Respiratory Panels Market:

• On July 11, 2025, Thermo Fisher Scientific announced the availability of the CE-IVD-marked Applied Biosystems TaqPath Respiratory Viral Select Panel.
• On April 14, 2025, the SARS-CoV-2 Respiratory Panel from QIAGEN, which can identify more than 20 infections from a single patient sample, is anticipated to be made accessible in Japan in the near future.

Key Segments

By Panel Type:

• Multiplex Panels
• Syndromic Panels
• Targeted Panels

By Usage Type:

• Diagnostic Use
• Research Use

By Technique:

• Polymerase Chain Reaction (PCR)
• Reverse Transcription Polymerase Chain Reaction (RT-PCR)
• Real-time Polymerase Chain Reaction (qPCR)
• Next-Generation Sequencing (NGS)

By End User:

• Hospitals
• Diagnostic Centers
• Academic & Research Institutions
• Ambulatory Diagnostic Centers

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East & Africa